Drugs Made In America Acquisition II Corp. (NasdaqGM: DMII)
Financials · Capital Markets · US
$10.14
+0.10% today · +2.5% 1Y
Drugs Made In America Acquisition II Corp. (NasdaqGM: DMII) operates in the Capital Markets industry within the Financials sector. The company is valued at $645.28M and employs 2 people.
Over the last twelve months the share price has gained 2.5%, trading between 9.86 and 10.20.
Tweenvest scores Drugs Made In America Acquisition II Corp. across four factors: quality 7/100. Its strongest factor is quality.
DMII price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $645.28M
- Revenue (TTM)
- —
- P/E
- 49.57
- EPS
- 0.21
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $10.20
- 52-week low
- $9.86
- Avg volume (3M)
- —
- Shares outstanding
- 63.70M
- Employees
- 2
- Next earnings
- —
About Drugs Made In America Acquisition II Corp.
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company was founded in 2024 and maintains its principal office in Fort Lauderdale, Florida.
- Founded
- 2024
- Listed since
- Dec 4, 2025
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Capital Markets companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETFARCA: VTI | $2.31T | $378.24 | +0.44% |
| Vanguard Index Funds - Vanguard S&P 500 ETFARCA: VOO | $1.66T | $703.71 | +0.39% |
| iShares Trust - iShares Core S&P 500 ETFARCA: IVV | $893.67B | $769.31 | +0.39% |
| State Street SPDR S&P 500 ETF TrustARCA: SPY | $821.60B | $765.72 | +0.41% |
| Invesco QQQ Trust, Series 1NasdaqGM: QQQ | $487.14B | $713.44 | +0.36% |
| Vanguard Index Funds - Vanguard Morningstar Growth ETFARCA: VUG | $378.44B | $87.50 | +0.38% |
| Morgan StanleyNYSE: MS | $336.42B | $214.20 | +3.25% |
| The Goldman Sachs Group, Inc.NYSE: GS | $314.66B | $1,039.28 | +3.73% |
Figures last refreshed Aug 18, 2026.